Results 301 to 310 of about 94,577 (347)

Designer drugs.

Texas medicine, 1989
Designer drugs are synthetic analogs of substances with known psychoactive properties. These analogs are dangerous due to their direct pharmacological effects and the presence of toxic by-products that occur during synthesis. Three groups of designer drugs are reviewed (fentanyl, meperidine, and methamphetamine analogs), and their psychoactive effects ...
openaire   +1 more source

Application of Nanotechnology in Cancer Therapy and Imaging

Ca-A Cancer Journal for Clinicians, 2008
Dong M Shin
exaly  

Recent developments in esophageal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2013
Jesper Lagergren, Pernilla Lagergren
exaly  

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

Designer Drugs

Alcoholism Treatment Quarterly, 1988
openaire   +1 more source

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Paola Guglielmelli
exaly  

Drug Design

2017
Christian Betzel, Arayik Martirosyan
openaire   +1 more source

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

Ca-A Cancer Journal for Clinicians, 2017
Paul J Hoskins, Walter H Gotlieb
exaly  

Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates

Ca-A Cancer Journal for Clinicians, 2006
David M Goldenberg
exaly  

Structure-Based Drug Design (Rational Drug Design)

2004
openaire   +1 more source